Literature DB >> 18834627

Understanding deficient elimination of uric acid.

Martin Aringer1, Juergen Graessler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18834627     DOI： 10.1016/S0140-6736(08)61344-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  Additive composite ABCG2, SLC2A9 and SLC22A12 scores of high-risk alleles with alcohol use modulate gout risk.

Authors:  Hung-Pin Tu; Chia-Min Chung; Albert Min-Shan Ko; Su-Shin Lee; Han-Ming Lai; Chien-Hung Lee; Chung-Ming Huang; Chiu-Shong Liu; Ying-Chin Ko
Journal:  J Hum Genet       Date:  2016-05-26       Impact factor: 3.172

2.  Variants of ALPK1 with ABCG2, SLC2A9, and SLC22A12 increased the positive predictive value for gout.

Authors:  Hung-Pin Tu; Albert Min-Shan Ko; Su-Shin Lee; Chi-Pin Lee; Tzer-Min Kuo; Chung-Ming Huang; Ying-Chin Ko
Journal:  J Hum Genet       Date:  2017-11-08       Impact factor: 3.172

3.  [Crystal-induced activation of the inflammasome: gout and pseudogout].

Authors:  M Winzer; A-K Tausche; M Aringer
Journal:  Z Rheumatol       Date:  2009-11       Impact factor: 1.372

Review 4.  Gout--current diagnosis and treatment.

Authors:  Anne-Kathrin Tausche; Tim L Jansen; Hans-Egbert Schröder; Stefan R Bornstein; Martin Aringer; Ulf Müller-Ladner
Journal:  Dtsch Arztebl Int       Date:  2009-08-24       Impact factor: 5.594

5.  Plasma uric acid level indicates tubular interstitial leisions at early stage of IgA nephropathy.

Authors:  Jingjing Zhou; Yuqing Chen; Ying Liu; Sufang Shi; Xueying Li; Suxia Wang; Hong Zhang
Journal:  BMC Nephrol       Date:  2014-01-14       Impact factor: 2.388
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.